Identify nanobodies that can efficiently cross the blood-brain barrier (BBB) and can be used to deliver anti-brain cancer drugs.

Develop and use a smart in vivo screen that marks an improvement over the limited current lab models.

Build on this knowledge to start the development of effective BBB-crossing therapeutics for brain cancer.